133 related articles for article (PubMed ID: 7524899)
1. Glycolipids noncovalently bound to DEAE-Sephadex. Use of the complexes for purification of IgM and IgG anti-(Gal beta 1-->3 GalNAc-) antibodies.
Rodriguez PE; Barra JL; Cumar FA
Biochem Mol Biol Int; 1994 May; 33(2):273-81. PubMed ID: 7524899
[TBL] [Abstract][Full Text] [Related]
2. Gangliosides noncovalently bound to DEAE-Sephadex: application to purification of anti-ganglioside antibodies.
Rodriguez PE; Cumar FA
Anal Biochem; 1990 Jul; 188(1):48-52. PubMed ID: 2221368
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
Gregson NA; Koblar S; Hughes RA
Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
[TBL] [Abstract][Full Text] [Related]
4. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
Caudie C; Vial C; Petiot P; Bancel J; Lombard C; Gonnaud PM
Ann Biol Clin (Paris); 2001; 59(5):567-77. PubMed ID: 11602387
[TBL] [Abstract][Full Text] [Related]
5. Anti-fucosyl-GM1 ganglioside IgG and IgM autoantibodies in human serum: no link to pathology.
Adler G; Pacuszka T; Strugalska M; Targońska I; Panasiewicz M; Lewartowska A
Immunol Lett; 1996 Sep; 52(2-3):89-93. PubMed ID: 8905401
[TBL] [Abstract][Full Text] [Related]
6. Human IgM monoclonal proteins that bind 3-fucosyllactosamine, asialo-GM1, and GM1.
Marcus DM; Perry L; Gilbert S; Preud'homme JL; Kyle R
J Immunol; 1989 Nov; 143(9):2929-32. PubMed ID: 2572647
[TBL] [Abstract][Full Text] [Related]
7. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
8. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications.
Kusunoki S; Morita D; Ohminami S; Hitoshi S; Kanazawa I
Muscle Nerve; 2003 Mar; 27(3):302-6. PubMed ID: 12635116
[TBL] [Abstract][Full Text] [Related]
9. N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome.
Odaka M; Yuki N; Yoshino H; Kasama T; Handa S; Irie F; Hirabayashi Y; Suzuki A; Hirata K
Ann Neurol; 1998 Jun; 43(6):829-34. PubMed ID: 9629854
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K
J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994
[TBL] [Abstract][Full Text] [Related]
11. Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves.
Yoshino H; Ariga T; Suzuki A; Yu RK; Miyatake T
Brain Res; 2008 Aug; 1227():216-20. PubMed ID: 18598683
[TBL] [Abstract][Full Text] [Related]
12. Cloning of human anti-GM1 antibodies from motor neuropathy patients.
Willison HJ; Paterson G; Kennedy PG; Veitch J
Ann Neurol; 1994 Apr; 35(4):471-8. PubMed ID: 8154875
[TBL] [Abstract][Full Text] [Related]
13. Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome.
Ilyas AA; Mithen FA; Chen ZW; Cook SD
J Neurol Sci; 1991 Mar; 102(1):67-75. PubMed ID: 1856733
[TBL] [Abstract][Full Text] [Related]
14. Solid phase immunoadsorption for therapeutic and analytical studies on neuropathy-associated anti-GM1 antibodies.
Townson K; Boffey J; Nicholl D; Veitch J; Bundle D; Zhang P; Samain E; Antoine T; Bernardi A; Arosio D; Sonnino S; Isaacs N; Willison HJ
Glycobiology; 2007 Mar; 17(3):294-303. PubMed ID: 17145744
[TBL] [Abstract][Full Text] [Related]
15. High affinity of anti-GM1 antibodies is associated with disease onset in experimental neuropathy.
Comín R; Yuki N; Lopez PH; Nores GA
J Neurosci Res; 2006 Oct; 84(5):1085-90. PubMed ID: 16881049
[TBL] [Abstract][Full Text] [Related]
16. A kinetics approach to the characterization of an IgM specific for the glycolipid asialo-GM1.
Harrison BA; MacKenzie R; Hirama T; Lee KK; Altman E
J Immunol Methods; 1998 Mar; 212(1):29-39. PubMed ID: 9671150
[TBL] [Abstract][Full Text] [Related]
17. Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier.
Moran AP; Annuk H; Prendergast MM
J Neuroimmunol; 2005 Aug; 165(1-2):179-85. PubMed ID: 15993494
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides.
Wirguin I; Suturkova-Milosevic L; Della-Latta P; Fisher T; Brown RH; Latov N
Ann Neurol; 1994 Jun; 35(6):698-703. PubMed ID: 8210226
[TBL] [Abstract][Full Text] [Related]
19. Human monoclonal IgM anti-Gal(beta 1-3)GalNAc autoantibodies bind to the surface of bovine spinal motoneurons.
Thomas FP; Thomas JE; Sadiq SA; van den Berg LH; Roelofs RI; Latov N; Hays AP
J Neuropathol Exp Neurol; 1990 Mar; 49(2):89-95. PubMed ID: 1689771
[TBL] [Abstract][Full Text] [Related]
20. Unusual presence of anti-GM1 IgG-antibodies in a healthy individual, and their possible involvement in the origin of disease-associated anti-GM1 antibodies.
Lardone RD; Alaniz ME; Irazoqui FJ; Nores GA
J Neuroimmunol; 2006 Apr; 173(1-2):174-9. PubMed ID: 16376437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
